Castrate-resistant Prostate Cancer Treatment and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Castrate-resistant Prostate Cancer Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Castrate-resistant Prostate Cancer Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Castrate-resistant Prostate Cancer Treatment Overall Market Size
2.1 Global Castrate-resistant Prostate Cancer Treatment Market Size: 2021 VS 2028
2.2 Global Castrate-resistant Prostate Cancer Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Castrate-resistant Prostate Cancer Treatment Players in Global Market
3.2 Top Global Castrate-resistant Prostate Cancer Treatment Companies Ranked by Revenue
3.3 Global Castrate-resistant Prostate Cancer Treatment Revenue by Companies
3.4 Top 3 and Top 5 Castrate-resistant Prostate Cancer Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Castrate-resistant Prostate Cancer Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Castrate-resistant Prostate Cancer Treatment Players in Global Market
3.6.1 List of Global Tier 1 Castrate-resistant Prostate Cancer Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Castrate-resistant Prostate Cancer Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Castrate-resistant Prostate Cancer Treatment Market Size Markets, 2021 & 2028
4.1.2 Chemotherapy
4.1.3 Hormonal Therapy
4.1.4 Immunotherapy
4.1.5 Radiotherapy
4.2 By Type - Global Castrate-resistant Prostate Cancer Treatment Revenue & Forecasts
4.2.1 By Type - Global Castrate-resistant Prostate Cancer Treatment Revenue, 2017-2022
4.2.2 By Type - Global Castrate-resistant Prostate Cancer Treatment Revenue, 2023-2028
4.2.3 By Type - Global Castrate-resistant Prostate Cancer Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Castrate-resistant Prostate Cancer Treatment Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Castrate-resistant Prostate Cancer Treatment Revenue & Forecasts
5.2.1 By Application - Global Castrate-resistant Prostate Cancer Treatment Revenue, 2017-2022
5.2.2 By Application - Global Castrate-resistant Prostate Cancer Treatment Revenue, 2023-2028
5.2.3 By Application - Global Castrate-resistant Prostate Cancer Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Castrate-resistant Prostate Cancer Treatment Market Size, 2021 & 2028
6.2 By Region - Global Castrate-resistant Prostate Cancer Treatment Revenue & Forecasts
6.2.1 By Region - Global Castrate-resistant Prostate Cancer Treatment Revenue, 2017-2022
6.2.2 By Region - Global Castrate-resistant Prostate Cancer Treatment Revenue, 2023-2028
6.2.3 By Region - Global Castrate-resistant Prostate Cancer Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Castrate-resistant Prostate Cancer Treatment Revenue, 2017-2028
6.3.2 US Castrate-resistant Prostate Cancer Treatment Market Size, 2017-2028
6.3.3 Canada Castrate-resistant Prostate Cancer Treatment Market Size, 2017-2028
6.3.4 Mexico Castrate-resistant Prostate Cancer Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Castrate-resistant Prostate Cancer Treatment Revenue, 2017-2028
6.4.2 Germany Castrate-resistant Prostate Cancer Treatment Market Size, 2017-2028
6.4.3 France Castrate-resistant Prostate Cancer Treatment Market Size, 2017-2028
6.4.4 U.K. Castrate-resistant Prostate Cancer Treatment Market Size, 2017-2028
6.4.5 Italy Castrate-resistant Prostate Cancer Treatment Market Size, 2017-2028
6.4.6 Russia Castrate-resistant Prostate Cancer Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Castrate-resistant Prostate Cancer Treatment Market Size, 2017-2028
6.4.8 Benelux Castrate-resistant Prostate Cancer Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Castrate-resistant Prostate Cancer Treatment Revenue, 2017-2028
6.5.2 China Castrate-resistant Prostate Cancer Treatment Market Size, 2017-2028
6.5.3 Japan Castrate-resistant Prostate Cancer Treatment Market Size, 2017-2028
6.5.4 South Korea Castrate-resistant Prostate Cancer Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Castrate-resistant Prostate Cancer Treatment Market Size, 2017-2028
6.5.6 India Castrate-resistant Prostate Cancer Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Castrate-resistant Prostate Cancer Treatment Revenue, 2017-2028
6.6.2 Brazil Castrate-resistant Prostate Cancer Treatment Market Size, 2017-2028
6.6.3 Argentina Castrate-resistant Prostate Cancer Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Castrate-resistant Prostate Cancer Treatment Revenue, 2017-2028
6.7.2 Turkey Castrate-resistant Prostate Cancer Treatment Market Size, 2017-2028
6.7.3 Israel Castrate-resistant Prostate Cancer Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Castrate-resistant Prostate Cancer Treatment Market Size, 2017-2028
6.7.5 UAE Castrate-resistant Prostate Cancer Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Sanofi
7.1.1 Sanofi Corporate Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Castrate-resistant Prostate Cancer Treatment Major Product Offerings
7.1.4 Sanofi Castrate-resistant Prostate Cancer Treatment Revenue in Global Market (2017-2022)
7.1.5 Sanofi Key News
7.2 Johnson & Johnson Services, Inc.
7.2.1 Johnson & Johnson Services, Inc. Corporate Summary
7.2.2 Johnson & Johnson Services, Inc. Business Overview
7.2.3 Johnson & Johnson Services, Inc. Castrate-resistant Prostate Cancer Treatment Major Product Offerings
7.2.4 Johnson & Johnson Services, Inc. Castrate-resistant Prostate Cancer Treatment Revenue in Global Market (2017-2022)
7.2.5 Johnson & Johnson Services, Inc. Key News
7.3 Pfizer, Inc.
7.3.1 Pfizer, Inc. Corporate Summary
7.3.2 Pfizer, Inc. Business Overview
7.3.3 Pfizer, Inc. Castrate-resistant Prostate Cancer Treatment Major Product Offerings
7.3.4 Pfizer, Inc. Castrate-resistant Prostate Cancer Treatment Revenue in Global Market (2017-2022)
7.3.5 Pfizer, Inc. Key News
7.4 Astellas Pharma, Inc.
7.4.1 Astellas Pharma, Inc. Corporate Summary
7.4.2 Astellas Pharma, Inc. Business Overview
7.4.3 Astellas Pharma, Inc. Castrate-resistant Prostate Cancer Treatment Major Product Offerings
7.4.4 Astellas Pharma, Inc. Castrate-resistant Prostate Cancer Treatment Revenue in Global Market (2017-2022)
7.4.5 Astellas Pharma, Inc. Key News
7.5 Bayer AG
7.5.1 Bayer AG Corporate Summary
7.5.2 Bayer AG Business Overview
7.5.3 Bayer AG Castrate-resistant Prostate Cancer Treatment Major Product Offerings
7.5.4 Bayer AG Castrate-resistant Prostate Cancer Treatment Revenue in Global Market (2017-2022)
7.5.5 Bayer AG Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Castrate-resistant Prostate Cancer Treatment Market Opportunities & Trends in Global Market
Table 2. Castrate-resistant Prostate Cancer Treatment Market Drivers in Global Market
Table 3. Castrate-resistant Prostate Cancer Treatment Market Restraints in Global Market
Table 4. Key Players of Castrate-resistant Prostate Cancer Treatment in Global Market
Table 5. Top Castrate-resistant Prostate Cancer Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Castrate-resistant Prostate Cancer Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Castrate-resistant Prostate Cancer Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Castrate-resistant Prostate Cancer Treatment Product Type
Table 9. List of Global Tier 1 Castrate-resistant Prostate Cancer Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Castrate-resistant Prostate Cancer Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Castrate-resistant Prostate Cancer Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Castrate-resistant Prostate Cancer Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Castrate-resistant Prostate Cancer Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Castrate-resistant Prostate Cancer Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Castrate-resistant Prostate Cancer Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Castrate-resistant Prostate Cancer Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Sanofi Corporate Summary
Table 31. Sanofi Castrate-resistant Prostate Cancer Treatment Product Offerings
Table 32. Sanofi Castrate-resistant Prostate Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Johnson & Johnson Services, Inc. Corporate Summary
Table 34. Johnson & Johnson Services, Inc. Castrate-resistant Prostate Cancer Treatment Product Offerings
Table 35. Johnson & Johnson Services, Inc. Castrate-resistant Prostate Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer, Inc. Corporate Summary
Table 37. Pfizer, Inc. Castrate-resistant Prostate Cancer Treatment Product Offerings
Table 38. Pfizer, Inc. Castrate-resistant Prostate Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Astellas Pharma, Inc. Corporate Summary
Table 40. Astellas Pharma, Inc. Castrate-resistant Prostate Cancer Treatment Product Offerings
Table 41. Astellas Pharma, Inc. Castrate-resistant Prostate Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Bayer AG Corporate Summary
Table 43. Bayer AG Castrate-resistant Prostate Cancer Treatment Product Offerings
Table 44. Bayer AG Castrate-resistant Prostate Cancer Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Castrate-resistant Prostate Cancer Treatment Segment by Type in 2021
Figure 2. Castrate-resistant Prostate Cancer Treatment Segment by Application in 2021
Figure 3. Global Castrate-resistant Prostate Cancer Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Castrate-resistant Prostate Cancer Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Castrate-resistant Prostate Cancer Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Castrate-resistant Prostate Cancer Treatment Revenue in 2021
Figure 8. By Type - Global Castrate-resistant Prostate Cancer Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Castrate-resistant Prostate Cancer Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Castrate-resistant Prostate Cancer Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Castrate-resistant Prostate Cancer Treatment Revenue Market Share, 2017-2028
Figure 12. US Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Castrate-resistant Prostate Cancer Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Castrate-resistant Prostate Cancer Treatment Revenue Market Share, 2017-2028
Figure 24. China Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Castrate-resistant Prostate Cancer Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Castrate-resistant Prostate Cancer Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Castrate-resistant Prostate Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Sanofi Castrate-resistant Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Johnson & Johnson Services, Inc. Castrate-resistant Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer, Inc. Castrate-resistant Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Astellas Pharma, Inc. Castrate-resistant Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bayer AG Castrate-resistant Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
